Dendritic cell vaccine induces antigen-specific CD8<sup>+</sup> T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade.

Nagaoka, Koji; Hosoi, Akihiro; Iino, Tamaki; Morishita, Yasuyuki; Matsushita, Hirokazu; Kakimi, Kazuhiro

Dendritic cell vaccine induces antigen-specific CD8⁺ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade.

Nagaoka, Koji; Hosoi, Akihiro; Iino, Tamaki; Morishita, Yasuyuki; Matsushita, Hirokazu; Kakimi, Kazuhiro.

Afiliação

Nagaoka K; Department of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Hosoi A; Medinet Co. Ltd., Kohoku-Ku, Yokohama, Japan.
Iino T; Department of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Morishita Y; Medinet Co. Ltd., Kohoku-Ku, Yokohama, Japan.
Matsushita H; Department of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan.
Kakimi K; Medinet Co. Ltd., Kohoku-Ku, Yokohama, Japan.

Oncoimmunology ; 7(3): e1395124, 2018.

Article em En | MEDLINE | ID: mdl-29399391